Vaccine News and Research

Latest Vaccine News and Research

KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

KHN’s ‘What the Health?’: We may be done with covid, but covid’s not done with us

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

MHRA authorizes new medicine for COVID-19 prevention

MHRA authorizes new medicine for COVID-19 prevention

Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

Study finds serum antibody levels after BNT162b2 booster dropped significantly but remained higher than after the second dose

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

Covid vaccination not linked to increased risk of rare neurological events

Covid vaccination not linked to increased risk of rare neurological events

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Frail and older males more vulnerable to COVID-19 than females

Frail and older males more vulnerable to COVID-19 than females

Vaccine effectiveness against COVID-19 severity in the elderly

Vaccine effectiveness against COVID-19 severity in the elderly

Study suggests expanding vaccination to children aged 5-11 would provide benefits to the US population

Study suggests expanding vaccination to children aged 5-11 would provide benefits to the US population

Evidence of lower COVID-19 severity in SARS-CoV-2 Omicron infection compared to Delta infection

Evidence of lower COVID-19 severity in SARS-CoV-2 Omicron infection compared to Delta infection

Study explores profiles of COVID-19 vaccines across different countries

Study explores profiles of COVID-19 vaccines across different countries

Inhalable ‘aerogel’ induces immune response against COVID-19 in the lungs of mice

Inhalable ‘aerogel’ induces immune response against COVID-19 in the lungs of mice

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

Potential Covid-19 vaccine may offer an inexpensive, easy-to-store alternative to RNA vaccines

Potential Covid-19 vaccine may offer an inexpensive, easy-to-store alternative to RNA vaccines

Sneaking large drug-carrying biological molecules into cells using a novel drug delivery system

Sneaking large drug-carrying biological molecules into cells using a novel drug delivery system

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.